Prognostic Value of Combined LMR and CEA Dynamic Monitoring in Postoperative Colorectal Cancer Patients

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789. doi:10.1002/ijc.33588
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-310912
   PubMed Web of Science ®Google Scholar
• Li N, Lu B, Luo C, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and northern America. Cancer Lett. 2021;522:255–268. doi:10.1016/j.canlet.2021.09.034
   PubMed Web of Science ®Google Scholar
• Kahi CJ, Boland CR, Dominitz JA, et al. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US multi-society task force on colorectal cancer. Gastroenterology. 2016;150(3):758–768 e11. doi:10.1053/j.gastro.2016.01.001
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 2016;2016:6058147. doi:10.1155/2016/6058147
   PubMed Web of Science ®Google Scholar
• Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14(6):e218–e228. doi:10.1016/s1470-2045(12)70582-x
   PubMed Web of Science ®Google Scholar
• Guo GF, Wang YX, Zhou YX, et al. Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes. J Immunother Cancer. 2019;7(1). doi:10.1186/s40425-019-0656-3
   Web of Science ®Google Scholar
• Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell. 2006;124(2):263–266. doi:10.1016/j.cell.2006.01.007
   PubMed Web of Science ®Google Scholar
• Aziz MH, Sideras K, Aziz NA, et al. The systemic-immune-inflammation index independently predicts survival and recurrence in resectable pancreatic cancer and its prognostic value depends on bilirubin levels: a Retrospective Multicenter Cohort Study. Ann Surg. 2019;270(1):139–146. doi:10.1097/SLA.0000000000002660
   PubMed Web of Science ®Google Scholar
• Moon G, Noh H, Cho IJ, Lee JI, Han A. Prediction of late recurrence in patients with breast cancer: elevated neutrophil to lymphocyte ratio (NLR) at 5 years after diagnosis and late recurrence. Breast Cancer. 2020;27(1):54–61. doi:10.1007/s12282-019-00994-z
   PubMed Web of Science ®Google Scholar
• Chan JCY, Chan DL, Diakos CI, et al. The lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancer. Ann Surg. 2017;265(3):539–546. doi:10.1097/Sla.0000000000001743
   PubMed Web of Science ®Google Scholar
• Chan JCY, Diakos CI, Chan DLH, et al. A longitudinal investigation of inflammatory markers in colorectal cancer patients perioperatively demonstrates benefit in serial remeasurement. Ann Surg. 2018;267(6):1119–1125. doi:10.1097/SLA.0000000000002251
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Kawada K, Obama K. Inflammation-related biomarkers for the prediction of prognosis in colorectal cancer patients. Int J Mol Sci. 2021;22(15):8002. doi:10.3390/ijms22158002
   PubMed Web of Science ®Google Scholar
• Nost TH, Alcala K, Urbarova I, et al. Systemic inflammation markers and cancer incidence in the UK Biobank. Eur J Epidemiol. 2021;36(8):841–848. doi:10.1007/s10654-021-00752-6
   PubMed Web of Science ®Google Scholar
• Fest J, Ruiter R, Mulder M, et al. The systemic immune-inflammation index is associated with an increased risk of incident cancer-A population-based cohort study. Int J Cancer. 2020;146(3):692–698. doi:10.1002/ijc.32303
   PubMed Web of Science ®Google Scholar
• Yasui K, Shida D, Nakamura Y, Ahiko Y, Tsukamoto S, Kanemitsu Y. Postoperative, but not preoperative, inflammation-based prognostic markers are prognostic factors in stage III colorectal cancer patients. Br J Cancer. 2020;124(5):933–941. doi:10.1038/s41416-020-01189-6
   PubMed Web of Science ®Google Scholar
• You Q, Fang T, Yin X, et al. Serum CD4 is associated with the infiltration of CD4+T cells in the tumor microenvironment of gastric cancer. J Immunol Res. 2021;2021:1–13. doi:10.1155/2021/6539702
   Web of Science ®Google Scholar
• Hagland HR, Lea D, Watson MM, SØReide K. Correlation of blood T-cells to intratumoural density and location of CD3+ and CD8+ T-cells in colorectal cancer. Anticancer Res. 2017;37(2):675–684. doi:10.21873/anticanres.11363
   PubMed Web of Science ®Google Scholar
• Claude L, Perol D, Ray-Coquard I, et al. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Radiother Oncol. 2005;76(3):334–339. doi:10.1016/j.radonc.2005.06.004
   PubMed Web of Science ®Google Scholar
• Ray-Coquard I, Cropet C, Van Glabbeke M, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res. 2009;69(13):5383–5391. doi:10.1158/0008-5472.Can-08-3845
   PubMed Web of Science ®Google Scholar
• Seliger B, Massa C. Modulation of lymphocyte functions in the microenvironment by tumor oncogenic pathways. Front Immunol. 2022;13:883639. doi:10.3389/fimmu.2022.883639
   PubMed Web of Science ®Google Scholar
• Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234(6):8509–8521. doi:10.1002/jcp.27782
   PubMed Web of Science ®Google Scholar
• Tan BH, Shi XJ, Zhang J, et al. Inhibition of Rspo-Lgr4 facilitates checkpoint blockade therapy by switching macrophage polarization. Cancer Res. 2018;78(17):4929–4942. doi:10.1158/0008-5472.Can-18-0152
   PubMed Web of Science ®Google Scholar
• Shimura T, Shibata M, Gonda K, et al. Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells. Fukushima J Med Sci. 2018;64(2):64–72. doi:10.5387/fms.2018-10
   PubMed Web of Science ®Google Scholar
• Yaping W, Zhe W, Zhuling C, et al. The soldiers needed to be awakened: tumor-infiltrating immune cells. Front Genet. 2022;13. doi:10.3389/fgene.2022.988703
   PubMed Web of Science ®Google Scholar
• Tesi RJ. MDSC; the most important cell you have never heard of. Trends Pharmacol Sci. 2019;40(1):4–7. doi:10.1016/j.tips.2018.10.008
   PubMed Web of Science ®Google Scholar
• Lewis ED, Wu D, Meydani SN. Age-associated alterations in immune function and inflammation. Prog Neuropsychopharmacol Biol Psychiatry. 2022;118:110576. doi:10.1016/j.pnpbp.2022.110576
   PubMed Web of Science ®Google Scholar
• Lisanti C, Basile D, Garattini SK, et al. The SAFFO Study: sex-related prognostic role and cut-off definition of Monocyte-to-Lymphocyte Ratio (MLR) in metastatic colorectal cancer. Cancers. 2023;15(1). doi:10.3390/cancers15010175
   Web of Science ®Google Scholar
• Conforti F, Pala L, Goldhirsch A. Different effectiveness of anticancer immunotherapy in men and women relies on sex-dimorphism of the immune system. Oncotarget. 2018;9(58):31167–31168. doi:10.18632/oncotarget.25795
   PubMedGoogle Scholar
• Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–638. doi:10.1038/nri.2016.90
   PubMed Web of Science ®Google Scholar
• Kitakaze M, Fujino S, Miyoshi N, et al. Tumor-infiltrating T cells as a risk factor for lymph node metastasis in patients with submucosal colorectal cancer. Sci Rep. 2023;13(1). doi:10.1038/s41598-023-29260-1
   Web of Science ®Google Scholar
• Wang Q, Li S, Qiao S, Zheng Z, Duan X, Zhu X. Changes in T lymphocyte subsets in different tumors before and after radiotherapy: a meta-analysis. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.648652
   Web of Science ®Google Scholar
• Waidhauser J, Schuh A, Trepel M, Schmälter A-K, Rank A. Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer. Cancer Immunol Immunother. 2020;69(1):147–157. doi:10.1007/s00262-019-02449-y
   PubMed Web of Science ®Google Scholar
• Sorensen CG, Karlsson WK, Pommergaard HC, Burcharth J, Rosenberg J. The diagnostic accuracy of carcinoembryonic antigen to detect colorectal cancer recurrence - A systematic review. Int J Surg. 2016;25:134–144. doi:10.1016/j.ijsu.2015.11.065
   PubMed Web of Science ®Google Scholar
• Nicholson BD, Shinkins B, Mant D. Blood measurement of carcinoembryonic antigen level for detecting recurrence of colorectal cancer. JAMA. 2016;316(12):1310–1311. doi:10.1001/jama.2016.11212
   PubMed Web of Science ®Google Scholar
• Korner H, Soreide K, Stokkeland PJ, Soreide JA. Diagnostic accuracy of serum-carcinoembryonic antigen in recurrent colorectal cancer: a receiver operating characteristic curve analysis. Ann Surg Oncol. 2007;14(2):417–423. doi:10.1245/s10434-006-9060-6
   PubMed Web of Science ®Google Scholar
• He Q, Du S, Wang X, et al. Development and validation of a nomogram based on neutrophil-to-lymphocyte ratio and fibrinogen-to-lymphocyte ratio for predicting recurrence of colorectal adenoma. J Gastrointest Oncol. 2022;13(5):2269–2281. doi:10.21037/jgo-22-410
   PubMed Web of Science ®Google Scholar